R&D Why the best CROs challenge the trial plan and keep challeng... Too often, oncology trials fail for reasons that could have been anticipated and addressed.
Oncology Sponsored Global oncology innovation from Hengrui Pharma Hengrui Pharma's strategic ambition in oncology has focused on translating scientific innovation into meaningful treatment options for patients.
Patients Innovation can transform NHS care, but scaling is the missin... Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients
R&D Go north: Life sciences excellence shines bright in Sweden Gothenburg is Sweden's fastest-growing and second largest city region and one of Europe's leading innovation regions.
R&D Why are eCOA studies still so challenging? Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.
Digital Disruptive healthtech, personalisation & investment appetite Bringing genuinely transformative healthcare innovations from concept to commercial reality is becoming increasingly complex.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.